Abstract
To assess the efficacy and safety of radiofrequency volumetric thermal ablation (RFVTA) in women with symptomatic fibroids and moderate-to-severe menorrhagia, in terms of mean menstrual blood loss, incidence of device-related adverse events, and surgical re-intervention.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
